trending Market Intelligence /marketintelligence/en/news-insights/trending/m6pVuqprb_5ylol2wJomsQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

AbbVie promotes chief scientific officer to president role; IsoRay names CEO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

AbbVie promotes chief scientific officer to president role; IsoRay names CEO

S&P Global Market Intelligence presents a weekly rundown of recent executive changes at pharmaceutical, biotech and life sciences companies.

* AbbVie Inc. promoted Michael Severino as vice chairman and president. Severino was previously the North Chicago, Ill.-based company's executive vice president for research and development and chief scientific officer.

* IsoRay Inc. named Lori Woods as CEO. Woods has been serving as the company's interim CEO since June.

* Vertex Pharmaceuticals Inc. said Thomas Graney has resigned from his role as the company's CFO. Graney will remain as an employee of Vertex and help in the transition until February 2019.

* U.K.-based Summit Therapeutics plc said Erik Ostrowski is stepping down as the company's CFO by the end of December.

* Sweden's Medivir AB said Richard Bethell is leaving his post as the company's chief scientific officer.

* NeoGenomics Inc. has named Lawrence Weiss the company's chief scientific officer.

* Ziopharm Oncology Inc. said it promoted David Mauney to the president role. Mauney joined the company in 2017 as executive vice president and chief business officer.

* Bellicum Pharmaceuticals Inc. said it appointed Atabak Mokari as CFO.

* Sosei Group Corp. said Peter Bains is resigning from his roles as president, CEO and board member of the company, effective Dec. 31. Bains will be replaced by Shinichi Tamura, executive chairman, founder and former CEO of Sosei, effective Jan. 1, 2019.

* Adaptimmune Therapeutics plc said Gwen Binder is stepping down as the company's chief technology officer by the end of January 2019.

* Tvardi Therapeutics Inc. has appointed Imran Alibhai CEO and board member.

* Synthetic Biologics Inc. named Steven Shallcross CEO and director. Shallcross, who previously served as the company's interim CEO, will also continue his role as Synthetic Biologics' CFO.